These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26001340)

  • 21. Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives.
    Shahzad SA; Yar M; Bajda M; Shahzadi L; Khan ZA; Naqvi SA; Mutahir S; Mahmood N; Khan KM
    Bioorg Chem; 2015 Jun; 60():37-41. PubMed ID: 25920005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
    Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
    Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues.
    Zaman K; Rahim F; Taha M; Ullah H; Wadood A; Nawaz M; Khan F; Wahab Z; Shah SAA; Rehman AU; Kawde AN; Gollapalli M
    Bioorg Chem; 2019 Aug; 89():103024. PubMed ID: 31176853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
    Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
    Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.
    Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M
    Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel N-arylidenequinoline-3-carbohydrazides as potent β-glucuronidase inhibitors.
    Taha M; Sultan S; Nuzar HA; Rahim F; Imran S; Ismail NH; Naz H; Ullah H
    Bioorg Med Chem; 2016 Aug; 24(16):3696-704. PubMed ID: 27312423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropyrimidones: As novel class of β-glucuronidase inhibitors.
    Ali F; Khan KM; Salar U; Iqbal S; Taha M; Ismail NH; Perveen S; Wadood A; Ghufran M; Ali B
    Bioorg Med Chem; 2016 Aug; 24(16):3624-35. PubMed ID: 27325448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis: Small library of hybrid scaffolds of benzothiazole having hydrazone and evaluation of their β-glucuronidase activity.
    Taha M; Arbin M; Ahmat N; Imran S; Rahim F
    Bioorg Chem; 2018 Apr; 77():47-55. PubMed ID: 29331764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.
    Akhtar T; Khan MA; Iqbal J; Jones PG; Hameed S
    Chem Biol Drug Des; 2014 Jul; 84(1):92-8. PubMed ID: 24495281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.
    Menteşe E; Yılmaz F; Emirik M; Ülker S; Kahveci B
    Bioorg Chem; 2018 Feb; 76():478-486. PubMed ID: 29306066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.
    Taha M; Ismail NH; Imran S; Rashwan H; Jamil W; Ali S; Kashif SM; Rahim F; Salar U; Khan KM
    Bioorg Chem; 2016 Apr; 65():48-56. PubMed ID: 26855413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-glucuronidase inhibitory studies on coumarin derivatives.
    Khan KM; Fakhri MI; Shaikh NN; Saad SM; Hussain S; Perveen S; Choudhary MI
    Med Chem; 2014; 10(8):778-82. PubMed ID: 24611780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Antifungal Potential of Some Novel Benzimidazole-1,3,4-Oxadiazole Compounds.
    Karaburun AÇ; Kaya Çavuşoğlu B; Acar Çevik U; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Atlı Ö; Koparal AS; Kaplancıklı ZA
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30621357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of novel disulfide and sulfone hybrid scaffolds as potent β-glucuronidase inhibitor.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Al Muqarrabin LM; Zaki HM; Ahmat N; Nasir A; Khan F
    Bioorg Chem; 2016 Oct; 68():15-22. PubMed ID: 27414468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
    Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
    Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
    Khan KM; Saad SM; Shaikh NN; Hussain S; Fakhri MI; Perveen S; Taha M; Choudhary MI
    Bioorg Med Chem; 2014 Jul; 22(13):3449-54. PubMed ID: 24844756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.
    Bandarage U; Hare B; Parsons J; Pham L; Marhefka C; Bemis G; Tang Q; Moody CS; Rodems S; Shah S; Adams C; Bravo J; Charonnet E; Savic V; Come JH; Green J
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5191-4. PubMed ID: 19632115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.
    Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S
    Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.